GoodRx rolls out brand medication savings program at Kroger pharmacies
RxSmartSaver powered by GoodRx delivers instant affordability at the pharmacy counter, giving consumers easier access to savings on widely used brand-name medications.
Pharmacy
CVS Caremark seeking a possible $200 copay for Wegovy and Zepbound
Although $200 is a steep monthly co-pay for a covered brand-name medication, it’s still significantly lower than the $500 price Novo Nordisk charges through its direct-to-consumer platform for uninsured individuals.
2025 PBM audit insights: What pharmacies need to know heading into 2026
By Harini Bupathi, Esq. partner, Frier Levitt’s Life Sciences Group
New local data in GSK and IQVIA's Vaccine Track supports smarter public health action at the community level
New analysis of metro-area data reveals wide variation in adult vaccination trends across the US and points to opportunities for local action.
CVS Health remains committed to Nashville with $120,000 investment in Cul2vate’s “Roots and Roofs” initiative
Investment strengthens local organizations to advance food access, workforce development, and housing stability in underserved communities.
Aetna 2026 Medicare Advantage aims to deliver access to affordable, personalized care
Leveraging the strength of the CVS Health family of companies to deliver differentiated member experiences.
Pfizer signs major agreement with U.S. government to lower drug costs
Voluntary agreement meets the President’s four requests while also protecting the U.S. ecosystem responsible for America’s leadership in delivering medical breakthroughs.
NACDS and NCPA issue statements on White House pharmaceutical website and drug-pricing announcement
“The President’s announcement reflects the reality that pharmacy benefit manager (PBM) tactics are exploding Americans’ prescription drug costs, and this action is an attempt to strike a blow against the PBMs’ manipulation and self-enrichment in the prescription drug supply chain."
CRN criticizes FDA over drug preclusion ruling
FDA declined to issue guidance or rulemaking, which CRN said will stifle innovation and perpetuate conflict between supplement makers and pharmaceutical companies.
API industry growth accelerates as US drives demand
The US is the largest market for APIs, fueled by high drug use, strong regulation, and top biotech manufacturing.
Cardinal Health to expand pharmaceutical distribution network with new facility in Indianapolis
The state-of-the-art forward distribution center will feature automation and the latest technology advancements in support of the segment's distribution of more than 70,000 pharmaceutical and specialty deliveries daily across the United States.
Health care funding on the line in shutdown showdown
A prolonged government shutdown would result in significant disruptions to health care funding and oversight.
AbbVie breaks ground on new API facility in North Chicago
AbbVie said the site will be fully operational by 2027, enabling API production for select European and Asian products in the U.S.
GSK CEO Emma Walmsley to step down
Walmsley made history in 2017 as the first woman to lead a top-tier pharmaceutical company.
CVS Health expands senior care through Oak Street, Signify and MinuteClinic
CVS Health’s business units focus on making care for adults over 65 more accessible and coordinated.
Camber releases Voriconazole for Injection
Voriconazole for Injection is indicated for a variety of fungal infections in adult and pediatric patients (2 years of age and older).